InspireMD (NASDAQ: NSPR) reported Q3 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.5 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.